OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!

Can Cancer Spread From a Biopsy? Here's What Research Says

• Dr. Dino Prato - Envita Medical Centers • Season 1 • Episode 75

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 11:23

This video addresses a common patient fear: whether a biopsy might lead to cancer spread.

We provide honest data and health education, explaining that while biopsy-related seeding is real, the information gained through procedures like lung biopsies is critical for early detection and treatment. Our aim is to empower you with health tips to make informed decisions without hype or false reassurances.

🎯 What You’ll Learn in This Episode:
- Whether biopsies can really spread cancer
- How rare biopsy-related seeding actually is
- Why technique matters more than the needle
- What the coaxial needle technique is and why it’s safer
- The role of liquid biopsies and circulating tumor cells
- When biopsy risk is already irrelevant due to existing spread
- Why deep molecular and immune testing matters more than fear
- The right questions to ask before agreeing to a biopsy

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more:
www.envita.com
📞 Speak with a care coordinator: 866-830-4576


“Good data saves lives. Fear delays answers.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

 https://www.scirp.org/journal/paperinformation?paperid=132493